Impact of 6‐versus 12‐month dual antiplatelet therapy on clinical prognosis in patients with high bleeding risk: Insights from the 4‐year results of the I LOVE IT 2 study

J Zhang, M Qiu, K Na, S Ma, Z Jiang… - Catheterization and …, 2021 - Wiley Online Library
Objectives To explore the impact of 6‐versus 12‐month dual antiplatelet therapy (DAPT) on
the clinical prognosis of high bleeding risk (HBR) patients. Background The optimal DAPT …
被引用次数：6 相关文章

Impact of 6-versus 12-month dual antiplatelet therapy on clinical prognosis in patients with high bleeding risk: Insights from the 4-year results of the I LOVE IT 2 study.

J Zhang, M Qiu, K Na, S Ma, Z Jiang, J Li… - … : Official Journal of the …, 2021 - europepmc.org
Impact of 6- versus 12-month dual antiplatelet therapy on clinical prognosis in patients with
high bleeding risk: Insights from the 4-year results of the I LOVE IT 2 study. - Abstract - Europe …

Impact of 6-versus 12-month dual antiplatelet therapy on clinical prognosis in patients with high bleeding risk: Insights from the 4-year results of the I LOVE IT 2 study

J Zhang, M Qiu, K Na, S Ma, Z Jiang… - … : official journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Objectives To explore the impact of 6-versus 12-month dual antiplatelet therapy (DAPT) on
the clinical prognosis of high bleeding risk (HBR) patients. Background The optimal DAPT …